Reprocessed Medical Devices Market By Type (Cardiovascular Devices, Laparoscopic Devices, Gastroenterology Devices, General Surgery Devices, Orthopedic Devices), By End-Use (Hospitals, Home Healthcare) , Industry Size, Growth, Share And Forecast To 2022

Published By: Brisk Insights | Published On: Aug 7, 2016

Key Findings


The global reprocessed medical devices market has beenprojected to grow at the CAGR of 20.3% market during 2016-2022. In 2014, the markethas generated the revenue of $1.14 billion and now it has been expected to reach up to $5 billion in terms of revenue by 2022.The significant pressure on hospitals and other healthcare settings to work under a limited budget and the long-term cost effectiveness associated with recovering are the important drivers of the overall industry. In addition, increasing concern relating to a high capacity of waste and landfills generated worldwide is instrumental in shifting the focus towards the reprocessing. Moreover, the market has beenanticipated to exhibit exponential growth due to the rising preference of physicians towards single-use reprocessed devices as a patient safety measure due to the reduced risk of infection and a step towards constant medical waste reductionhas been also boosting the market of reprocessed medical devices.


The global reprocessed medical devices market segment has been also expected to grow due to increasing number of critical as well as non-critical cardiovascular reprocessed products approved by the FDA, has been fuelling the market of reprocessed medical devices. In the cardiovascular segment, diagnostic electrophysiology catheters holds the largest share due to cost savings and a similar degree of effectiveness exhibited by these medical devices as compare to the original device. According to the National Institutes of Health, reprocessed diagnostic electrophysiology catheters resulted in a 41.2% reduction in the total costs incurred. In addition, the laparoscopy segment holds the second largest market share owing to the increasing demand for minimally invasive techniques helps to bring the opportunities for more recycling approvals, spearheading the growth for the laparoscopic segment during the forecasted period.


Market Segment Insight


On the basis of segmentation, the global reprocessed medical devices market is segmented in to two parts type and end users. On the basis of type, the market of reprocessed medical devices is segmented as cardiovascular devices, laparoscopic devices, gastroenterology devices, general surgery devices and orthopaedic devices. Cardiovascular devices is further segmented as blood pressure cuffs, positioning devices, cardiac stabilization devices, diagnostic electrophysiology catheters, deep vein thrombosis compression sleeves and electrophysiology cables. The laparoscopic devices is further segmented as harmonic scalpels and endoscopic trocars. The gastroenterology devices is further segmented as biopsy forceps and similarly the general surgery devices is further segmented as pressure bags and balloon inflation devices. The cardiovascular segment dominates over 55.0% of the overall reprocessed medical devices market, as a significance of its growing incorporation in cardiac surgeries, such as diagnostics electrophysiology catheters, cardiac positioning and stabilization devices, and blood pressure cuffs in a inclusive range of diagnostic, blood pressure monitoring, and surgical applications in 2014.On the basis of end users, the market of reprocessed medical devices is further segmented as hospitals and home healthcare.


Regional Insight


Geographically, the global reprocessed medical devices market in to the major regions of North America, Europe, Asia Pacific, and Rest of the World. North America holds the largest revenue share of overall reprocessed medical devices market in 2014 at over 50.0% and it wasstrongly followed by Europe. Due tothe presence of government and intergovernmental waste management organizations involved in the application of sustainable waste strategies and adoption of productivity without compromising patient’s safety are accountable for widening the base of potential growth prospect inthe North American market. Asia Pacific has beenanticipatedto be the fastest growing market over the forecasted period due to the existence of untouched opportunities in emerging economies. These countries include China and India, with growing focus towards overall cost reduction. Moreover, increasing investment of industry players in the form of manufacturing facility set up in this region has been predicted to present with a higher degree of growth potential during the forecasted period.


Competitive Insights


Some of the major market players areAgito Medical A/S , Block Imaging International, Inc. , Centurion Medical Products Corporation , DRE, Inc. , GE Healthcare , Hygia Health Services, Inc. , Medisiss , Philips Healthcare , Radiology Oncology Systems, Inc. , Siemens Healthcare , Soma Technology, Inc. , Sterilmed,Stryker Sustainability Solutions,Suretek Medical,VANGUARD AG.Acquisition, mergers, innovation and expansions are the key strategies adopted by the market players to sustain in the market.In 2015,GE Healthcarehas announced to expand its healthcare consulting business with the acquisition of the Camden Group for undisclosed terms.

CHAP 1. METHODOLOGY & SCOPE 12
1.1. RESEARCH METHODOLOGY 12
1.2. RESEARCH SCOPE & ASSUMPTIONS 12
1.3. LIST OF DATA SOURCES 12


CHAP 2. EXECUTIVE SUMMARY 13
2.1. GLOBAL REPROCESSED MEDICAL DEVICES MARKET SUMMARY & KEY BUYING CRITERIA 13
2.2. GLOBAL REPROCESSED MEDICAL DEVICES MARKET OUTLOOK 13
2.3. MARKET SEGMENTATION ANALYSIS 13
2.4. MARKET SIZE AND GROWTH PROSPECTS 2012-2022 13
2.5. GLOBAL REPROCESSED MEDICAL DEVICES MARKET VALUE CHAIN ANALYSIS 13
2.6. VENDOR LANDSCAPE 13


CHAP 3. GLOBAL REPROCESSED MEDICAL DEVICES MARKET DETERMINENTS 14
3.1. MARKET DRIVER ANALYSIS 14
3.2. MARKET RESTRAINT ANALYSIS 14
3.3. KEY OPPORTUNITIES 14
3.4. CHALLENGES 14


CHAP 4. INDUSTRY ANALYSIS 15
4.1. GLOBAL REPROCESSED MEDICAL DEVICES MARKET– PORTER’S FIVE FORCE MODEL 15
4.2. GLOBAL REPROCESSED MEDICAL DEVICES MARKET– PESTEL ANALYSIS 15
4.3. GLOBAL REPROCESSED MEDICAL DEVICES MARKET– GAP ANALYSIS 15


CHAP 5. GLOBAL REPROCESSED MEDICAL DEVICES MARKET BY TYPE 2012-2022 ($ MILLION) 16
5.1. GLOBAL REPROCESSED MEDICAL DEVICES MARKET BY CARDIOVASCULAR DEVICES 2012-2022($ MILLION) 17
5.2. GLOBAL REPROCESSED MEDICAL DEVICES MARKET BY LAPAROSCOPIC DEVICES 2012-2022 ($ MILLION) 17
5.3. GLOBAL REPROCESSED MEDICAL DEVICES MARKET BY GASTROENTEROLOGY DEVICES 2012-2022 ($ MILLION) 17
5.4. GLOBAL REPROCESSED MEDICAL DEVICES MARKET BY GENERAL SURGERY DEVICES 2012-2022 ($ MILLION) 17
5.5. GLOBAL REPROCESSED MEDICAL DEVICES MARKET BY ORTHOPEDIC DEVICES 2012-2022 ($ MILLION) 18


CHAP 6. GLOBAL REPROCESSED MEDICAL DEVICES MARKET BY END-USE 2012-2022 ($ MILLION) 19
6.1. GLOBAL REPROCESSED MEDICAL DEVICES MARKET BY HOSPITALS 2012-2022 ($ MILLION) 19
6.2. GLOBAL REPROCESSED MEDICAL DEVICES MARKET BY HOME HEALTHCARE 2012-2022 ($ MILLION) 19
6.3. GLOBAL REPROCESSED MEDICAL DEVICES MARKET BY OTHERS 2012-2022 ($ MILLION) 19


CHAP 7. GLOBAL REPROCESSED MEDICAL DEVICES MARKET REGIONAL OUTLOOK 2012-2022 ($ MILLION) 21
7.1. GLOBAL REPROCESSED MEDICAL DEVICES MARKET BY REGION 2012-2022 ($ MILLION) 21
7.2. NORTH AMERICA 21
7.2.1. NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
7.2.2. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
7.2.3. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 21
7.2.3.1. U.S. 21
7.2.3.1.1. U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
7.2.3.1.2. U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
7.2.3.2. CANADA 21
7.2.3.2.1. CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
7.2.3.2.2. CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
7.3. EUROPE 21
7.3.1. EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
7.3.2. EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
7.3.3. EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 21
7.3.3.1. GERMANY 21
7.3.3.1.1. GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 22
7.3.3.1.2. GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 22
7.3.3.2. UK 22
7.3.3.2.1. UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 22
7.3.3.2.2. UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 22
7.3.3.3. FRANCE 22
7.3.3.3.1. FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 22
7.3.3.3.2. FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 22
7.3.3.4. SPAIN 22
7.3.3.4.1. SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 22
7.3.3.4.2. SPAIN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 22
7.3.3.5. REST OF EUROPE 22
7.3.3.5.1. RUSSIA MARKET ESTIMATES AND FORECAST2012-2022($ MILLION) 23
7.3.3.5.2. OTHERS MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($ MILLION) 23
7.4. ASIA PACIFIC 23
7.4.1. ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 23
7.4.2. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 23
7.4.3. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 23
7.4.3.1. CHINA 23
7.4.3.1.1. CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 23
7.4.3.1.2. CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 23
7.4.3.2. INDIA 23
7.4.3.2.1. INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 23
7.4.3.2.2. INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 23
7.4.3.3. JAPAN 23
7.4.3.3.1. JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 23
7.4.3.3.2. JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 23
7.4.3.4. OTHERS 23
7.4.3.4.1. OTHER MARKET ESTIMATES AND FORECASTS 2012-2022($ MILLION) 24
7.4.3.4.2. OTHER MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($ MILLION) 24
7.5. MIDDLE EAST & AFRICA 24
7.5.1. MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 24
7.5.2. MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 24
7.6. LATIN AMERICA 24
7.6.1. LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 24
7.6.2. LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 24
7.6.2.1. BRAZIL 24
7.6.2.1.1. BRAZIL MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 24
7.6.2.1.2. BRAZIL MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 24


CHAP 8. COMPETITIVE LANDSCAPE 25
8.1. AGITO MEDICAL A/S 26
8.1.2. SCOT ANALYSIS 26
8.1.3. PRODUCT BENCHMARKING 26
8.1.4. STRATEGIC INITIATIVES 26
8.2. BLOCK IMAGING INTERNATIONAL, INC. 26
8.2.1. COMPANY OVERVIEW 26
8.2.2. SCOT ANALYSIS 26
8.2.3. PRODUCT BENCHMARKING 26
8.2.4. STRATEGIC INITIATIVES 26
8.3. CENTURION MEDICAL PRODUCTS CORPORATION 26
8.3.1. COMPANY OVERVIEW 26
8.3.2. SCOT ANALYSIS 26
8.3.3. PRODUCT BENCHMARKING 26
8.3.4. STRATEGIC INITIATIVES 26
8.4. DRE, INC. 26
8.4.1. COMPANY OVERVIEW 26
8.4.2. SCOT ANALYSIS 26
8.4.3. PRODUCT BENCHMARKING 26
8.4.4. STRATEGIC INITIATIVES 26
8.5. GE HEALTHCARE 26
8.5.1. COMPANY OVERVIEW 26
8.5.2. SCOT ANALYSIS 26
8.5.3. PRODUCT BENCHMARKING 26
8.5.4. STRATEGIC INITIATIVES 26
8.6. HYGIA HEALTH SERVICES, INC. 26
8.6.1. COMPANY OVERVIEW 26
8.6.2. SCOT ANALYSIS 27
8.6.3. PRODUCT BENCHMARKING 27
8.6.4. STRATEGIC INITIATIVES 27
8.7. MEDISISS 27
8.7.1. COMPANY OVERVIEW 27
8.7.2. SCOT ANALYSIS 27
8.7.3. PRODUCT BENCHMARKING 27
8.7.4. STRATEGIC INITIATIVES 27
8.8. PHILIPS HEALTHCARE 27
8.8.1. COMPANY OVERVIEW 27
8.8.2. SCOT ANALYSIS 27
8.8.3. PRODUCT BENCHMARKING 27
8.8.4. STRATEGIC INITIATIVES 27
8.9. RADIOLOGY ONCOLOGY SYSTEMS, INC. 27
8.9.1. COMPANY OVERVIEW 27
8.9.2. SCOT ANALYSIS 27
8.9.3. PRODUCT BENCHMARKING 27
8.9.4. STRATEGIC INITIATIVES 27
8.10. SIEMENS HEALTHCARE 27
8.10.1. COMPANY OVERVIEW 27
8.10.2. SCOT ANALYSIS 27
8.10.3. PRODUCT BENCHMARKING 27
8.10.4. STRATEGIC INITIATIVES 27
8.11. SOMA TECHNOLOGY, INC. 27
8.11.1. COMPANY OVERVIEW 27
8.11.2. SCOT ANALYSIS 27
8.11.3. PRODUCT BENCHMARKING 27
8.11.4. STRATEGIC INITIATIVES 28
8.12. STERILMED 28
8.12.1. COMPANY OVERVIEW 28
8.12.2. SCOT ANALYSIS 28
8.12.3. PRODUCT BENCHMARKING 28
8.12.4. STRATEGIC INITIATIVES 28
8.13. STRYKER SUSTAINABILITY SOLUTIONS 28
8.13.1. COMPANY OVERVIEW 28
8.13.2. SCOT ANALYSIS 28
8.13.3. PRODUCT BENCHMARKING 28
8.13.4. STRATEGIC INITIATIVES 28
8.14. SURETEK MEDICAL 28
8.14.1. COMPANY OVERVIEW 28
8.14.2. SCOT ANALYSIS 28
8.14.3. PRODUCT BENCHMARKING 28
8.14.4. STRATEGIC INITIATIVES 28
8.15. VANGUARD AG 28
8.15.1. COMPANY OVERVIEW 28
8.15.2. SCOT ANALYSIS 28
8.15.3. PRODUCT BENCHMARKING 28
8.15.4. STRATEGIC INITIATIVES 28

TABLE 1 GLOBAL REPROCESSED MEDICAL DEVICES MARKET BY TYPE 2012-2022 ($ MILLION) 29
TABLE 2 GLOBAL REPROCESSED MEDICAL DEVICES MARKET BY CARDIOVASCULAR DEVICES 2012-2022 ($ MILLION) 29
TABLE 3 GLOBAL REPROCESSED MEDICAL DEVICES MARKET BY BLOOD PRESSURE CUFFS 2012-2022 ($ MILLION) 29
TABLE 4 GLOBAL REPROCESSED MEDICAL DEVICES MARKET BY POSITIONING DEVICES 2012-2022 ($ MILLION) 29
TABLE 5 GLOBAL REPROCESSED MEDICAL DEVICES MARKET BY CARDIAC STABILIZATION DEVICES 2012-2022 ($ MILLION) 29
TABLE 6 GLOBAL REPROCESSED MEDICAL DEVICES MARKET BY DIAGNOSTIC ELECTROPHYSIOLOGY CATHETERS 2012-2022 ($ MILLION) 29
TABLE 7 GLOBAL REPROCESSED MEDICAL DEVICES MARKET BY DEEP VEIN THROMBOSIS COMPRESSION SLEEVES 2012-2022 ($ MILLION) 29
TABLE 8 GLOBAL REPROCESSED MEDICAL DEVICES MARKET BY ELECTROPHYSIOLOGY CABLES 2012-2022 ($ MILLION) 29
TABLE 9 GLOBAL REPROCESSED MEDICAL DEVICES MARKET BY 2012-2022 ($ MILLION) 29
TABLE 10 GLOBAL REPROCESSED MEDICAL DEVICES MARKET BY LAPAROSCOPIC DEVICES 2012-2022 ($ MILLION) 29
TABLE 11 GLOBAL REPROCESSED MEDICAL DEVICES MARKET BY HARMONIC SCALPELS 2012-2022 ($ MILLION) 29
TABLE 12 GLOBAL REPROCESSED MEDICAL DEVICES MARKET BY ENDOSCOPIC TROCARS 2012-2022 ($ MILLION) 29
TABLE 13 GLOBAL REPROCESSED MEDICAL DEVICES MARKET BY GASTROENTEROLOGY DEVICES 2012-2022 ($ MILLION) 29
TABLE 14 GLOBAL REPROCESSED MEDICAL DEVICES MARKET BY BIOPSY FORCEPS 2012-2022 ($ MILLION) 29
TABLE 15 GLOBAL REPROCESSED MEDICAL DEVICES MARKET BY OTHERS 2012-2022 ($ MILLION) 30
TABLE 16 GLOBAL REPROCESSED MEDICAL DEVICES MARKET BY GENERAL SURGERY DEVICES 2012-2022 ($ MILLION) 30
TABLE 17 GLOBAL REPROCESSED MEDICAL DEVICES MARKET BY PRESSURE BAGS 2012-2022 ($ MILLION) 30
TABLE 18 GLOBAL REPROCESSED MEDICAL DEVICES MARKET BY BALLOON INFLATION DEVICES 2012-2022 ($ MILLION) 30
TABLE 19 GLOBAL REPROCESSED MEDICAL DEVICES MARKET BY ORTHOPEDIC DEVICES 2012-2022 ($ MILLION) 30
TABLE 20 GLOBAL REPROCESSED MEDICAL DEVICES MARKET BY END-USE 2012-2022 ($ MILLION) 30
TABLE 21 GLOBAL REPROCESSED MEDICAL DEVICES MARKET BY HOSPITALS 2012-2022 ($ MILLION) 30
TABLE 22 GLOBAL REPROCESSED MEDICAL DEVICES MARKET BY HOME HEALTHCARE 2012-2022 ($ MILLION) 30
TABLE 23 GLOBAL REPROCESSED MEDICAL DEVICES MARKET BY OTHERS 2012-2022 ($ MILLION) 30
TABLE 24 NORTH AMERICA REPROCESSED MEDICAL DEVICES ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 30
TABLE 25 NORTH AMERICA REPROCESSED MEDICAL DEVICES ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 30
TABLE 26 NORTH AMERICA REPROCESSED MEDICAL DEVICES ESTIMATES AND FORECAST BY REGION 2012 – 2022 ($ MILLION) 30
TABLE 27 U.S. REPROCESSED MEDICAL DEVICES ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 30
TABLE 28 U.S. REPROCESSED MEDICAL DEVICES ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 30
TABLE 29 CANADA REPROCESSED MEDICAL DEVICES ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 30
TABLE 30 CANADA REPROCESSED MEDICAL DEVICES ESTIMATES AND FORECAST BY APPLICATION 2012 –2022 ($ MILLION) 30
TABLE 31 CANADA REPROCESSED MEDICAL DEVICES ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 30
TABLE 32 EUROPE REPROCESSED MEDICAL DEVICES ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 31
TABLE 33 EUROPE REPROCESSED MEDICAL DEVICES ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 31
TABLE 34 EUROPE REPROCESSED MEDICAL DEVICES ESTIMATES AND FORECAST BY REGION 2012 – 2022 ($ MILLION) 31
TABLE 35 GERMANY REPROCESSED MEDICAL DEVICES ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 31
TABLE 36 REPROCESSED MEDICAL DEVICES ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 31
TABLE 37 UK REPROCESSED MEDICAL DEVICES ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 31
TABLE 38 UK REPROCESSED MEDICAL DEVICES ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 31
TABLE 39 ASIA PACIFIC REPROCESSED MEDICAL DEVICES ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 31
TABLE 40 ASIA PACIFIC REPROCESSED MEDICAL DEVICES ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 31
TABLE 41 ASIA PACIFIC REPROCESSED MEDICAL DEVICES ESTIMATES AND FORECAST BY REGION 2012 – 2022 ($ MILLION) 31
TABLE 42 CHINA REPROCESSED MEDICAL DEVICES ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 31
TABLE 43 CHINA REPROCESSED MEDICAL DEVICES ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 31
TABLE 44 INDIA REPROCESSED MEDICAL DEVICES ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 31
TABLE 45 INDIA REPROCESSED MEDICAL DEVICES ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 31
TABLE 46 JAPAN REPROCESSED MEDICAL DEVICES ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 31
TABLE 47 JAPAN REPROCESSED MEDICAL DEVICES ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 31
TABLE 48 MIDDLE EAST & AFRICA REPROCESSED MEDICAL DEVICES ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 31
TABLE 49 MIDDLE EAST & AFRICA REPROCESSED MEDICAL DEVICES ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 32
TABLE 50 CENTRAL & SOUTH AMERICA REPROCESSED MEDICAL DEVICES ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 32
TABLE 51 CENTRAL & SOUTH AMERICA REPROCESSED MEDICAL DEVICES ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 32

FIGURE 1 MARKET SHARE BY REGIONS 32
FIGURE 2 UNITED STATES MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
FIGURE 3 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
FIGURE 4 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
FIGURE 5 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
FIGURE 6 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
FIGURE 7 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
FIGURE 8 APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
FIGURE 9 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
FIGURE 10 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
FIGURE 11 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
FIGURE 12 MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
FIGURE 13 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 33

Choose License


Contact Information

: 24/7 Research Support

: sales@briskinsights.com

: +448081890034 (UK)